Bis Hexanoyl (R)-1,3-Butanediol, a Novel Ketogenic Ester, Acutely Increases Circulating r- and s-ß-Hydroxybutyrate Concentrations in Healthy Adults.

Ketones beta-hydroxybutyrate exogenous ketone ketone di-ester ketone ester

Journal

Journal of the American Nutrition Association
ISSN: 2769-707X
Titre abrégé: J Am Nutr Assoc
Pays: United States
ID NLM: 9918300687506676

Informations de publication

Date de publication:
Feb 2023
Historique:
pubmed: 6 5 2022
medline: 26 1 2023
entrez: 5 5 2022
Statut: ppublish

Résumé

Ketosis has been reported to benefit healthspan and resilience, which has driven considerable interest in development of exogenous ketones to induce ketosis without dietary changes. Bis hexanoyl (R)-1,3-butanediol (BH-BD) is a novel ketone di-ester that can be used as a food ingredient that increases hepatic ketogenesis and blood beta-hydroxybutyrate (BHB) concentrations. Here, we provide the first description of blood ketone and metabolite kinetics for up to five hours after consumption of a beverage containing BH-BD by healthy adults ( Consumption of BH-BD effectively raised plasma r-BHB concentrations to 0.8-1.7 mM in all conditions, and both peak r-BHB concentration and r-BHB area under the curve were greater with 25 g versus 12.5 g of BH-BD. Urinary excretion of r-BHB was <1 g. Plasma concentration of the non-physiological isoform s-BHB was increased to 20-60 µM in all conditions. BH-BD consumption decreased plasma glucose and free fatty acid concentrations; insulin was increased when BH-BD was consumed with a meal. These results demonstrate that consumption of BH-BD effectively induces exogenous ketosis in healthy adults at rest.

Sections du résumé

BACKGROUND UNASSIGNED
Ketosis has been reported to benefit healthspan and resilience, which has driven considerable interest in development of exogenous ketones to induce ketosis without dietary changes. Bis hexanoyl (R)-1,3-butanediol (BH-BD) is a novel ketone di-ester that can be used as a food ingredient that increases hepatic ketogenesis and blood beta-hydroxybutyrate (BHB) concentrations.
METHODS UNASSIGNED
Here, we provide the first description of blood ketone and metabolite kinetics for up to five hours after consumption of a beverage containing BH-BD by healthy adults (
RESULTS UNASSIGNED
Consumption of BH-BD effectively raised plasma r-BHB concentrations to 0.8-1.7 mM in all conditions, and both peak r-BHB concentration and r-BHB area under the curve were greater with 25 g versus 12.5 g of BH-BD. Urinary excretion of r-BHB was <1 g. Plasma concentration of the non-physiological isoform s-BHB was increased to 20-60 µM in all conditions. BH-BD consumption decreased plasma glucose and free fatty acid concentrations; insulin was increased when BH-BD was consumed with a meal.
CONCLUSIONS UNASSIGNED
These results demonstrate that consumption of BH-BD effectively induces exogenous ketosis in healthy adults at rest.

Identifiants

pubmed: 35512774
doi: 10.1080/07315724.2021.2015476
doi:

Substances chimiques

3-Hydroxybutyric Acid TZP1275679
bis hexanoyl (R)-1,3-butanediol 0
Esters 0
Hydroxybutyrates 0
Ketone Bodies 0
Ketones 0

Types de publication

Journal Article Randomized Controlled Trial

Langues

eng

Sous-ensembles de citation

IM

Pagination

169-177

Auteurs

Christopher D Crabtree (CD)

Department of Human Sciences, The Ohio State University, Columbus, Ohio, USA.

Thanh Blade (T)

Buck Institute for Research on Aging, Novato, California, USA.

Parker N Hyde (PN)

Department of Human Sciences, The Ohio State University, Columbus, Ohio, USA.
Department of Kinesiology, University of North Georgia, Dahlonega, Georgia, USA.

Alex Buga (A)

Department of Human Sciences, The Ohio State University, Columbus, Ohio, USA.

Madison L Kackley (ML)

Department of Human Sciences, The Ohio State University, Columbus, Ohio, USA.

Teryn N Sapper (TN)

Department of Human Sciences, The Ohio State University, Columbus, Ohio, USA.

Oishika Panda (O)

Buck Institute for Research on Aging, Novato, California, USA.

Stephanie Roa-Diaz (S)

Buck Institute for Research on Aging, Novato, California, USA.

Joshua C Anthony (JC)

Juvenescence Ltd, Princeton, NJ, USA.
Nlumn LLC, Princeton, NJ, USA.

John C Newman (JC)

Buck Institute for Research on Aging, Novato, California, USA.
Division of Geriatrics, UCSF, San Francisco, California, USA.

Jeff S Volek (JS)

Department of Human Sciences, The Ohio State University, Columbus, Ohio, USA.

Brianna J Stubbs (BJ)

Buck Institute for Research on Aging, Novato, California, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH